Venus Remedies touches the roof as its R&D Centre gets accredited for GLP-OECD

05 Aug 2013 Evaluate

Venus Remedies is currently trading at its upper circuit limit of Rs. 160.50, up by 14.55 points or 9.97% from its previous closing of Rs. 145.95 on the BSE.

The scrip opened at Rs. 154.20 and has touched a high and low of Rs. 160.50 and Rs. 148.95 respectively. So far 26488 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 358.05 on 15-May-2013 and a 52 week low of Rs. 140.00 on 02-Aug-2013.

Last one week high and low of the scrip stood at Rs. 203.80 and Rs. 140.00 respectively. The current market cap of the company is Rs. 183.64 crore.

The promoters holding in the company stood at 43.99% while Institutions and Non-Institutions held 9.95% and 46.06% respectively.

Venus Remedies’ R&D Centre, Venus Medicine Research Centre (VMRC) has been accredited for Good Laboratory Practices (GLP) and norms on Organization for Economic Co-operation and Development (OECD) Principles by National GLP and Compliance Monitoring Authority (NGCMA). With this, VMRC has become one of the Top 25 Testing Labs of India to have received GLP approval.

Any research and development related data generated in VMRC will be acceptable by the registration authorities of all the OECD member countries such as USA, Japan, Europe and so on by the Organization for Economic Co-operation and Development (OECD) Principles of GLP in 1992, which helped promulgate GLP in many countries.

GLP accreditation, being one of the most coveted certification for R&D capabilities is another significant milestone for the company to ensure product quality, safety, reliability and excellence while preserving and improving human life through innovation. The certification is an attestation to the company's consistent reliability of the R&D tests, calibration performed in the testing labs and a documented quality management system.

Venus Remedies Share Price

749.05 -14.45 (-1.89%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×